Results 31 to 40 of about 1,913 (212)

Treatment chronic macular edema in Vogt-Koyanagi Harada syndrome with dexamethasone intravitreal implant: description of three case [PDF]

, 2015
Purpose: To report our experience with dexamethasone intravitreal implant (Ozurdex, DEX implant) in the chronic cystic macular edema (ME )with Vogt-Koyanagi-Harada (VKH) Syndrome. Method: A retrospective chart review of three patients with (VKH) treated
Albanese, Giorgio, Campagna, Orazio, Pacella, Elena, Pacella, Fernanda, Smaldone, Gianpaolo, Turchetti, Paolo   +5 more
core   +1 more source

Retrospective Analysis of Treatment Patterns in Pseudophakic Diabetic Macular Oedema Eyes Treated with Anti‐VEGF

Journal of Ophthalmology, Volume 2021, Issue 1, 2021., 2021
Background/Objectives. Currently, in England, antivascular endothelial growth factor (anti‐VEGF) is the first‐line treatment for diabetic macular oedema (DMO) where central macular thickness (CMT) is ≥400 microns. In pseudophakic eyes with suboptimal response to first‐line therapy, intravitreal corticosteroids may also be used.
Di Zou, Imran Jawaid, Winfried M. Amoaku, Marcel Menke   +3 more
wiley   +1 more source

Fluocinolone acetonide intravitreal implant as a therapeutic option for severe Sjögren’s syndrome-related keratopathy: a case report

Journal of Medical Case Reports, 2019
Background In this report, we present the results of a severe case of Sjögren’s syndrome-related keratopathy after fluocinolone acetonide 190-μg intravitreal implant (Iluvien®; Alimera Sciences Inc.) therapy.
Joanna Wasielica-Poslednik, Norbert Pfeiffer, Adrian Gericke   +2 more
doaj   +1 more source

Widening use of dexamethasone implant for the treatment of macular edema [PDF]

, 2017
Sustained-release intravitreal 0.7 mg dexamethasone (DEX) implant is approved in Europe for the treatment of macular edema related to diabetic retinopathy, branch retinal vein occlusion, central retinal vein occlusion, and non-infectious uveitis.
Avitabile T., Bonfiglio V., Fallico M., Fichera S., Longo A., Macchi I., Pizzo A., Rapisarda C., Reibaldi M., Russo A.   +9 more
core   +2 more sources

Analysis of urgent follow up visits and complications after intravitreal injections: a retrospective cohort study

International Journal of Retina and Vitreous, 2022
Background Intravitreal injections (IVIs), a common treatment in ophthalmology, result in acute complications and urgent follow-up visits causing significant burden to both patient and physician.
Alexander Miller, Matthew A. Wilneff, Andrew Yazji, Emily Petrinec, Michael Carbone, Chase Miller, Christina McCrossin, Richard Donkor, David G. Miller   +8 more
doaj   +1 more source

Comparison between “early” or “late” intravitreal injection of dexamethasone implant in branch (BRVO) or central (CRVO) retinal vein occlusion: six months follow-up [PDF]

, 2017
AIM: The aim of this study was to compare early and late injections of intravitreal dexamethasone implant in patients affected by central retinal vein occlusion (CRVO) or branch retinal vein occlusion (BRVO) with a six-months follow-up.
AUTOLITANO, MONICA, BASILI, Stefania, LA TORRE, Giuseppe, LENZI, TOMMASO, PACELLA, Elena, PACELLA, FERNANDA, Pascarella, Antonella   +6 more
core   +1 more source

Viral Retinitis following Intraocular or Periocular Corticosteroid Administration: A Case Series and Comprehensive Review of the Literature. [PDF]

, 2014
Purpose: To describe viral retinitis following intravitreal and periocular corticosteroid administration. Methods: Retrospective case series and comprehensive literature review. Results: We analyzed 5 unreported and 25 previously published cases of viral
Brown, D.M., Chan, C.C., Cunningham, E.T., Goldstein, D.A., Guex-Crosier, Y., Takakura, A., Tessler, H.H., Thorne, J.E., Wang, R.   +8 more
core   +1 more source

Recurrent Diabetic Macular Edema: What to Do

Case Reports in Ophthalmology, 2017
Diabetic macular edema (DME) is a leading cause of blindness in the working population. Herein, we report the case of a patient with recurrent DME for about 6 years, uncontrolled by several medical and surgical treatments, that was successfully treated ...
Rita Santos Gonçalves, Carla Teixeira, Pedro Coelho   +2 more
doaj   +1 more source

The outcome of fluocinolone acetonide intravitreal implant is predicted by the response to dexamethasone implant in diabetic macular oedema

Eye, 2021
To investigate if the visual and anatomic response to the first dexamethasone implant (DEX) predicts the 12-month clinical outcome after shifting to fluocinolone acetonide (FAc) implant in patients with diabetic macular oedema (DMO).Retrospective cohort study including pseudophakic patients with previously treated DMO, undergone one or more DEX ...
Cicinelli, M. V., Rosenblatt, A., Grosso, D., Zollet, P., Capone, L., Rabiolo, A., Lattanzio, R., Loewenstein, A., Bandello, F., Nassisi, M., Tan, A., Reynolds, R., Singh, S. R., Vaezi, K. P., Giocanti-Aurégan, A., Weinberg, T., Faes, L., Schwartz, R., Reyes, D. Y. A., Savastano, A., Touhami, S., Garcia, H. R., Pohlmann, D., Plant, A., Ventura, C. V., Chatziralli, I., Phasukkijwatana, N., Ruiz-Medrano, J., Yuan, M., Yılmaz, İ., Vogt, D., Ting, D. S. W., Mustapha, M., Mendaro, M.   +33 more
openaire   +7 more sources

Fluocinolone Acetonide 0.19 mg Implant in Patients with Cystoid Macular Edema Due To Irvine–Gass Syndrome

International Medical Case Reports Journal, 2021
João Heitor Marques,1 Ana Carolina Abreu,1 Nisa Silva,1 Angelina Meireles,1,2 Bernardete Pessoa,1,2 João Melo Beirão1,2 1Serviço de Oftalmologia, Centro Hospitalar e Universitário do Porto, Porto, Portugal; 2Instituto ...
Marques JH, Abreu AC, Silva N, Meireles A, Pessoa B, Melo Beirão J   +5 more
doaj